18th-22nd Conferences: Drug Abuse, Immune Modulation and AIDS

Information

  • Research Project
  • 9033239
  • ApplicationId
    9033239
  • Core Project Number
    R13DA023184
  • Full Project Number
    3R13DA023184-12S1
  • Serial Number
    023184
  • FOA Number
    PA-10-071
  • Sub Project Id
  • Project Start Date
    4/9/2007 - 17 years ago
  • Project End Date
    3/31/2016 - 8 years ago
  • Program Officer Name
    PUROHIT, VISHNUDUTT
  • Budget Start Date
    4/1/2015 - 9 years ago
  • Budget End Date
    3/31/2016 - 8 years ago
  • Fiscal Year
    2015
  • Support Year
    12
  • Suffix
    S1
  • Award Notice Date
    3/13/2015 - 9 years ago
Organizations

18th-22nd Conferences: Drug Abuse, Immune Modulation and AIDS

This is a competitive renewal application seeking funding support for the 18th-22nd Conferences of the Society on NeuroImmune Pharmacology (SNIP). The 18th SNIP Conference will be held in Honolulu, Hawaii from April 24-28, 2012. Subsequent conferences will be held in the Spring of 2013-2016. The aim of this conference is to identify the mechanisms by which substances of abuse (a) modulate the neuroimmune axis, (b) promote invasion by the HIV virus into the CNS, and (c) contribute to the development of neuroAIDS and related neuropathies. Symposia will address the interaction of a broad range of substances of abuse and HIV-related pathologies, including opportunistic pathogens, that affect the immune compromised host. Presentations selected by the SNIP Conference Committee will address the most recent advances in basic, clinical, and epidemiological research in neuroimmune pharmacology and substances of abuse, with particular emphasis on translational relevance. Topics at the 18th Conference will include: HIV latency and HIV reservoirs in the post-HAART era; alcohol, substance abuse, and neuroAIDS; rodent models of substance abuse and HIVassociated neurocognitive disorders (HAND); neuroimmunity and neurodegenerative diseases; and the emerging health risk posed by designer drugs, such as ?spice? and bath salts in the United States. Training of young investigators is of particular interest to the Society and the Conferences will include a young investigator poster session, a young investigator symposium, and traveling awards that will be given to exceptional young investigators. The Conferences are structured to promote ethnic and gender diversity among the speakers and participants, and accommodations for attendees with special needs will be provided. Information on upcoming Conferences, participant registration, and travel arrangements will be provided on the Society?s website. To share information presented at the Conference with the scientific community and publicat- large, meeting abstracts will be published in a Special Edition of the Journal of NeuroImmune Pharmacology, the official journal of SNIP, and highlights of the meeting will be disseminated through the Society?s website, brochure mailings, and personal contacts.

IC Name
NATIONAL INSTITUTE ON DRUG ABUSE
  • Activity
    R13
  • Administering IC
    DA
  • Application Type
    3
  • Direct Cost Amount
    17000
  • Indirect Cost Amount
  • Total Cost
    17000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    273
  • Ed Inst. Type
    SCHOOLS OF ARTS AND SCIENCES
  • Funding ICs
    NIAAA:17000\
  • Funding Mechanism
    OTHER RESEARCH-RELATED
  • Study Section
    ZDA1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SETON HALL UNIVERSITY
  • Organization Department
    PHARMACOLOGY
  • Organization DUNS
    079324315
  • Organization City
    SOUTH ORANGE
  • Organization State
    NJ
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    070792646
  • Organization District
    UNITED STATES